Delivery Order V797D70257-36C25218F2467

This federal contract award, valued at $5,526.76, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XERMELO 250 MG TABLET 84S, a pharmaceutical product, and is a Firm Fixed Price Delivery Order. The contract has an ultimate completion date of March 31, 2025 and was awarded on March 10, 2025. This contract award is associated with a larger Indefinite Delivery...

The Defense Logistics Agency awarded a $9,295.68 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the procurement of 84 boxes of Xermelo 250 mg tablets. The prime contractor will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by July 21, 2023 in support of the Defense Logistics Agency's logistics and procurement operations. No set aside designation or subcontractors were identified. The delivery order was awarded under an existing...

Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order valued at $9,295.70 by the Defense Logistics Agency (DLA) Troop Support Medical to supply 84 boxes of XERMELO 250 MG tablets. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with delivery by December 13, 2023. No set-aside designation was applied to this order, which was issued against an existing DLA contract vehicle to support the agency's provision of pharmaceuticals...

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,775.56 Firm Fixed Price Delivery Order is for the provision of 4566736117 XERMELO 250 MG TABLET 84S, a specialty medication. The contract has an ultimate completion date of January 8, 2025 and was awarded on December 16, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at...

The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a for-profit organization, to provide the pharmaceutical product XERMELO 250 MG TABLET 84S. The contract, valued at $19,160.74, has an ultimate completion date of April 9, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, is the prime contractor on this order. The contract is not associated with a larger vehicle and...

This federal contract award, valued at $5,526.76, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XERMELO 250 MG TABLET 84S, a pharmaceutical product, with a completion date of March 5, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of XERMELO 250 MG TABLET 84S, a specialty medication. The $9,232.06 firm fixed price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a wide range of pharmaceutical products and medical supplies to support military healthcare...

This delivery order, awarded by the Defense Logistics Agency Troop Support Medical to DMS Pharmaceutical Group Inc., is for the delivery of 120 capsules of XTANDI 40 MG CAPSULE. The potential value of this firm fixed price order is $4,311.35. Performance will occur in Park Ridge, Illinois with an anticipated completion date of October 6, 2023. No set-aside designation was used for this award placed under an unidentified medical supply vehicle. The Defense Logistics Agency Troop Support Medical...

This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of XATMEP 2.5 MG/ML ORAL SOLUTION 60ML. The contract has a completion date of March 1, 2024 and a potential value of $1,457.86. It does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on this award, which is likely part of a larger indefinite delivery contract (IDC) it...

This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order, with a potential value of $25,861.39, is for the supply of the pharmaceutical product Xeljanz XR 11 mg tablets. As a prime contractor, Amerisourcebergen Drug Corp has a history of providing a range of pharmaceutical products and medical supplies to support DLA Troop Support Medical programs. The...